PMAT variant rs3889348 is associated with metformin-induced gastrointestinal among Chinese type 2 diabetes patients.
Ziqing LiuXiao JiaPeng WuBenrui WuYing PanShao ZhongLuhua XiaoYuehong SongJinbo HuKaixin ZhouPublished in: Pharmacogenomics (2023)
Aim: This study examined intronic gene variants for their association with metformin intolerance in a Chinese population, focusing on the plasma monoamine transporter ( PMAT ) cis-protein expression quantitative trait loci (cis-eQTL) variant rs3889348. Methods: We recruited type 2 diabetes patients from two hospitals and identified 111 metformin-intolerant patients using a questionnaire, and selected 206 metformin-tolerant patients from 2180 type 2 diabetes mellitus patients. Genetic testing revealed an association between adverse gastrointestinal effects and SLC22A1 and PMAT . Results: The single-nucleotide polymorphism rs3889348 is associated with metformin-induced adverse gastrointestinal effects. Each additional copy of the G allele increases the score by 5.23 (95% CI: 1.82-8.64; p = 0.003). Patients taking more transporter inhibitors were more likely to respond to metformin-induced GI intolerance (p = 0.042). Conclusion: PMAT cis-eQTL rs3889348 was significantly associated with metformin-induced adverse gastrointestinal effects.
Keyphrases
- end stage renal disease
- type diabetes
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- healthcare
- emergency department
- genome wide
- gene expression
- skeletal muscle
- adipose tissue
- dna methylation
- mass spectrometry
- patient reported outcomes
- endothelial cells
- weight loss
- adverse drug
- electronic health record